{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:55:42Z","timestamp":1778511342068,"version":"3.51.4"},"reference-count":55,"publisher":"American Association for Cancer Research (AACR)","issue":"15","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The insulin-like growth factor binding protein IGFBP-3 is a proapoptotic and antiangiogenic protein in prostate cancer (CaP). Epidemiologic studies suggest that low IGFBP-3 is associated with greater risk of aggressive, metastatic prostate cancers, but in vivo functional data are lacking. Here we show that mice that are genetically deficient in IGFBP-3 exhibit weaker growth of primary prostate tumors but higher incidence of metastatic disease. Prostates in IGFBP-3 knockout mice (IGFBP-3KO mice) failed to undergo apoptosis after castration. Spontaneous prostate tumors did not develop in IGFBP-3KO mice, but splenic lymphomas occurred in 23% of female IGFBP-3KO mice by 80 weeks of age. To assess the effects of IGFBP-3 deficiency on prostate cancer development, we crossed IGFBP-3KO mice with a c-Myc\u2013driven model of CaP that develops slow-growing, nonmetastatic tumors. By 24 weeks of age, well-differentiated prostate cancers were observed in all mice regardless of IGFBP-3 status. However, by 80 weeks of age IGFBP-3KO mice tended to exhibit larger prostate tumors than control mice. More strikingly, lung metastases were observed at this time in 55% of the IGFBP-3KO mice but none in the control animals. Cell lines established from IGFBP-3KO:Myc tumors displayed more aggressive phenotypes in proliferation, invasion, and colony formation assays, relative to control Myc tumor cell lines. In addition, Myc:IGFBP-3KO cells exhibited evidence of epithelial\u2013mesenchymal transition. Our findings established a function for IGFBP-3 in suppressing metastasis in prostate cancer, and they also offered the first reported transgenic model of spontaneous metastatic prostate cancer for studies of this advanced stage of disease. Cancer Res; 71(15); 5154\u201363. \u00a92011 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-4513","type":"journal-article","created":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T00:04:27Z","timestamp":1308787467000},"page":"5154-5163","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["IGFBP-3 Is a Metastasis Suppression Gene in Prostate Cancer"],"prefix":"10.1158","volume":"71","author":[{"given":"Hemal H.","family":"Mehta","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglei","family":"Gao","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Galet","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladislava","family":"Paharkova","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxiang","family":"Wan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Said","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne J.","family":"Sohn","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Lawson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinchas","family":"Cohen","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Cobb","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuk-Wha","family":"Lee","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Pediatric Endocrinology, Mattel Children's Hospital; Departments of 2Urology and 3Pathology and Laboratory Medicine; and 4Division of Laboratory Animal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2011,7,28]]},"reference":[{"key":"2022061702560363600_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"2022061702560363600_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N Engl J Med"},{"key":"2022061702560363600_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1200\/JCO.2007.12.4008","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study","volume":"26","author":"Berthold","year":"2008","journal-title":"J Clin Oncol"},{"key":"2022061702560363600_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N Engl J Med"},{"key":"2022061702560363600_bib5","doi-asserted-by":"crossref","first-page":"C954","DOI":"10.1152\/ajpcell.00598.2008","article-title":"Perspectives in mammalian IGFBP-3 biology: local vs. systemic action","volume":"296","author":"Yamada","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"2022061702560363600_bib6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1006\/bbrc.1997.7089","article-title":"Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells","volume":"237","author":"Nickerson","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"2022061702560363600_bib7","doi-asserted-by":"crossref","first-page":"14877","DOI":"10.1074\/jbc.M200373200","article-title":"Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells","volume":"277","author":"Schwarze","year":"2002","journal-title":"J Biol Chem"},{"key":"2022061702560363600_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1677\/ERC-08-0175","article-title":"Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility","volume":"16","author":"Massoner","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"2022061702560363600_bib9","first-page":"1085","article-title":"cDNA microarray analysis with amplified RNA after isolation of intact cellular RNA from neoplastic and non-neoplastic prostate tissue separated by laser microdissections","volume":"24","author":"Thelen","year":"2004","journal-title":"Int J Oncol"},{"key":"2022061702560363600_bib10","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1158\/1078-0432.CCR-04-2160","article-title":"Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo","volume":"11","author":"Liu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2022061702560363600_bib11","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/sj.onc.1209977","article-title":"Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis","volume":"26","author":"Liu","year":"2007","journal-title":"Oncogene"},{"key":"2022061702560363600_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"2022061702560363600_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/jnci\/94.14.1099","article-title":"Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer","volume":"94","author":"Chan","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"2022061702560363600_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1200\/JCO.2002.20.3.833","article-title":"Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis","volume":"20","author":"Shariat","year":"2002","journal-title":"J Clin Oncol"},{"key":"2022061702560363600_bib15","first-page":"4407","article-title":"Insulin-like growth factor-binding protein-3 gene -202 A\/C polymorphism is correlated with advanced disease status in prostate cancer","volume":"63","author":"Wang","year":"2003","journal-title":"Cancer Res"},{"key":"2022061702560363600_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","article-title":"Myc-driven murine prostate cancer shares molecular features with human prostate tumors","volume":"4","author":"Ellwood-Yen","year":"2003","journal-title":"Cancer Cell"},{"key":"2022061702560363600_bib17","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1210\/en.2010-0672","article-title":"Evidence of a role for insulin-like growth factor binding protein (IGFBP)-3 in metabolic regulation","volume":"151","author":"Yamada","year":"2010","journal-title":"Endocrinology"},{"key":"2022061702560363600_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ghir.2007.07.007","article-title":"Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit","volume":"18","author":"Hwang","year":"2008","journal-title":"Growth Horm IGF Res"},{"key":"2022061702560363600_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"2022061702560363600_bib20","first-page":"3392","article-title":"Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins","volume":"59","author":"Nickerson","year":"1999","journal-title":"Cancer Res"},{"key":"2022061702560363600_bib21","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1046\/j.1464-410x.2000.00654.x","article-title":"Genes upregulated during castration-induced rat prostatic apoptosis: cloning and characterization of new cDNAs","volume":"85","author":"Bruyninx","year":"2000","journal-title":"BJU Int"},{"key":"2022061702560363600_bib22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/pros.20461","article-title":"Clusterin is not essential for androgen-regulated involution and regeneration of the normal mouse prostate","volume":"66","author":"Fink","year":"2006","journal-title":"Prostate"},{"key":"2022061702560363600_bib23","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/sj.onc.1203571","article-title":"The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo","volume":"19","author":"Bruckheimer","year":"2000","journal-title":"Oncogene"},{"key":"2022061702560363600_bib24","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.1073\/pnas.90.19.8910","article-title":"Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation","volume":"90","author":"Berges","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061702560363600_bib25","first-page":"1269","article-title":"Androgen suppressed apoptosis is modified in p53 deficient mice","volume":"10","author":"Colombel","year":"1995","journal-title":"Oncogene"},{"key":"2022061702560363600_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/377646a0","article-title":"Induction of the growth inhibitor IGF-binding protein 3 by p53","volume":"377","author":"Buckbinder","year":"1995","journal-title":"Nature"},{"key":"2022061702560363600_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ijc.25381","article-title":"Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004","volume":"128","author":"Nimptsch","year":"2011","journal-title":"Int J Cancer"},{"key":"2022061702560363600_bib28","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/en.2005-1270","article-title":"Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms","volume":"147","author":"Silha","year":"2006","journal-title":"Endocrinology"},{"key":"2022061702560363600_bib29","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1210\/en.2006-0195","article-title":"Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age","volume":"147","author":"Cohen","year":"2006","journal-title":"Endocrinology"},{"key":"2022061702560363600_bib30","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/onc.2010.79","article-title":"Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer","volume":"29","author":"Lee","year":"2010","journal-title":"Oncogene"},{"key":"2022061702560363600_bib31","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1038\/onc.2008.343","article-title":"Cadherins and cancer: how does cadherin dysfunction promote tumor progression?","volume":"27","author":"Jeanes","year":"2008","journal-title":"Oncogene"},{"key":"2022061702560363600_bib32","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm.2236","article-title":"Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance","volume":"16","author":"Tanaka","year":"2010","journal-title":"Nat Med"},{"key":"2022061702560363600_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature09677","article-title":"SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression","volume":"470","author":"Ding","year":"2011","journal-title":"Nature"},{"key":"2022061702560363600_bib34","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1083\/jcb.200601018","article-title":"The epithelial-mesenchymal transition: new insights in signaling, development, and disease","volume":"172","author":"Lee","year":"2006","journal-title":"J Cell Biol"},{"key":"2022061702560363600_bib35","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1158\/0008-5472.CAN-07-2559","article-title":"Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells","volume":"68","author":"Graham","year":"2008","journal-title":"Cancer Res"},{"key":"2022061702560363600_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00441-009-0902-y","article-title":"Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer","volume":"339","author":"Prasad","year":"2010","journal-title":"Cell Tissue Res"},{"key":"2022061702560363600_bib37","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1074\/jbc.272.18.12181","article-title":"Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism","volume":"272","author":"Rajah","year":"1997","journal-title":"J Biol Chem"},{"key":"2022061702560363600_bib38","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/MCB.25.5.2014-2030.2005","article-title":"The C terminus of p53 family proteins is a cell fate determinant","volume":"25","author":"Harms","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2022061702560363600_bib39","doi-asserted-by":"crossref","first-page":"16942","DOI":"10.1074\/jbc.M412757200","article-title":"Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha\/Nur77","volume":"280","author":"Lee","year":"2005","journal-title":"J Biol Chem"},{"key":"2022061702560363600_bib40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1074\/jbc.M307316200","article-title":"Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization","volume":"279","author":"Lee","year":"2004","journal-title":"J Biol Chem"},{"key":"2022061702560363600_bib41","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1210\/en.2006-0005","article-title":"Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes","volume":"147","author":"Burrows","year":"2006","journal-title":"Endocrinology"},{"key":"2022061702560363600_bib42","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/carcin\/bgm088","article-title":"Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3","volume":"28","author":"Lee","year":"2007","journal-title":"Carcinogenesis"},{"key":"2022061702560363600_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1677\/ERC-09-0106","article-title":"Nuclear export and mitochondrial and endoplasmic reticulum localization of IGF-binding protein 3 regulate its apoptotic properties","volume":"17","author":"Paharkova-Vatchkova","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"2022061702560363600_bib44","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/sj.onc.1210864","article-title":"Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma","volume":"27","author":"Torng","year":"2008","journal-title":"Oncogene"},{"key":"2022061702560363600_bib45","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1158\/1535-7163.MCT-06-0142","article-title":"Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition","volume":"5","author":"Oh","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"2022061702560363600_bib46","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1158\/1078-0432.CCR-08-0480","article-title":"Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741","volume":"14","author":"Fuchs","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2022061702560363600_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","article-title":"Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer","volume":"4","author":"Wang","year":"2003","journal-title":"Cancer Cell"},{"key":"2022061702560363600_bib48","first-page":"4096","article-title":"Metastatic prostate cancer in a transgenic mouse","volume":"56","author":"Gingrich","year":"1996","journal-title":"Cancer Res"},{"key":"2022061702560363600_bib49","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1158\/0008-5472.CAN-06-0486","article-title":"Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer","volume":"66","author":"Zhou","year":"2006","journal-title":"Cancer Res"},{"key":"2022061702560363600_bib50","doi-asserted-by":"crossref","first-page":"e9427","DOI":"10.1371\/journal.pone.0009427","article-title":"MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells","volume":"5","author":"Iwata","year":"2010","journal-title":"PLoS One"},{"key":"2022061702560363600_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/pros.21093","article-title":"Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model","volume":"70","author":"Nandana","year":"2010","journal-title":"Prostate"},{"key":"2022061702560363600_bib52","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev"},{"key":"2022061702560363600_bib53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/carcin\/bgp305","article-title":"Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells","volume":"31","author":"Dimri","year":"2010","journal-title":"Carcinogenesis"},{"key":"2022061702560363600_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbrc.2009.05.018","article-title":"c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells","volume":"385","author":"Kim","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"2022061702560363600_bib55","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1158\/0008-5472.CAN-08-3022","article-title":"NKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferation","volume":"69","author":"Muhlbradt","year":"2009","journal-title":"Cancer Res"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/71\/15\/5154\/2652299\/5154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/71\/15\/5154\/2652299\/5154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T07:44:30Z","timestamp":1655451870000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/71\/15\/5154\/567652\/IGFBP-3-Is-a-Metastasis-Suppression-Gene-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,28]]},"references-count":55,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2011,7,28]]},"published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-4513","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22388561","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22388555.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22388561.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22388558","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22388558.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22388555","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6502304.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6502304","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,28]]}}}